anmelden
Sanofi Aktie
73,89
EUR
-1,12
EUR
-1,49
%
69,14
CHF
+0,48
CHF
+0,70
%
Sanofi jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 90,20 Mrd. EUR
KGV 19,40Div. Rendite 4,98%WKN 920657
ISIN FR0000120578
Symbol SNYNF
AI Analyse
Kursziele der Sanofi-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Sanofi-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| RBC Capital Markets | 80,00 EUR | +8,18% | 08:01 Uhr | |
| Barclays Capital | 83,00 EUR | +12,24% | 08.09.2026 | |
| Deutsche Bank AG | 95,00 EUR | +28,47% | 02.09.2026 | |
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 105,00 EUR | +41,99% | 24.08.2026 | |
| UBS AG | 78,00 EUR | +5,48% | 19.08.2026 | |
| Jefferies & Company Inc. | 100,00 EUR | +35,23% | 07.08.2026 | |
| Bernstein Research | 106,21 EUR | +43,62% | 04.08.2026 | |
| JP Morgan Chase & Co. | 95,00 EUR | +28,47% | 31.07.2026 | |
| DZ BANK | - | - | 31.07.2026 | |
| Goldman Sachs Group Inc. | 84,00 EUR | +13,59% | 06.07.2026 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| Allergan Inc. | 0 | 0 | 0 | - | - |
| Amgen Inc. | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 8 | 0 | 1 | 163,88 GBP | - |
| Bayer | 7 | 2 | 0 | 56,56 EUR | +15,38% |
| BioNTech (ADRs) | 5 | 1 | 0 | 128,00 USD | +29,74% |
| CanSino Biologics Inc. Registered Shs -A- | 0 | 0 | 0 | - | - |
| CureVac | 0 | 0 | 0 | - | - |
| EVOTEC SE | 1 | 2 | 0 | 5,70 EUR | +89,75% |
| GSK PLC Registered Shs | 2 | 5 | 2 | 21,05 GBP | +16,91% |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 3 | 5 | 0 | 147,57 EUR | +12,31% |
| Moderna Inc | 0 | 1 | 0 | 45,00 USD | -67,93% |
| MorphoSys | 0 | 0 | 0 | - | - |
| Mylan N.V. | 0 | 0 | 0 | - | - |
| Novartis AG | 1 | 6 | 2 | 124,35 CHF | +12,19% |
| Novavax Inc. | 0 | 0 | 0 | - | - |
| Pfizer Inc. | 2 | 5 | 1 | 27,14 USD | -2,34% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 5 | 4 | 0 | 93,28 EUR | +26,16% |
| Shanghai Fosun Pharmaceutical (Group) Co Ltd (A) | 0 | 0 | 0 | - | - |
| Sinopharm Group Co Ltd (H) | 0 | 0 | 0 | - | - |
| Sinovac Biotech LtdShs | 0 | 0 | 0 | - | - |
| STADA | 0 | 0 | 0 | - | - |
| Teva Pharmaceutical Industries Ltd. (spons. ADRs) | 0 | 0 | 0 | - | - |
| Valneva | 0 | 0 | 0 | - | - |
| Warner Chilcott plc | 0 | 0 | 0 | - | - |
